The study group included 97 adults using liraglutide, 36 receiving semaglutide, 35 using tirzepatide and 82 receiving usual care without a GLP-1-based medication
The expression of NAMPT, the rate-limiting enzyme in the salvage NAD + biosynthetic pathway, decreases with aging and obesity in various organs, including in white and brown adipose tissue, liver, skeletal muscle, hippocampus, and retina [42,47,63,64,65,66]
BMI is less accurate for assessing healthy weight in some groups of people because it does not distinguish between the proportion of weight due to fat or muscle
CAS Number: 2381089-83-2
If you are also exploring related weight management options, check out Retatrutide benefits to see how this medication stands out from others in its class
Results showed that participants in the Retatrutide groups experienced significant fat loss, ranging from -7.2% to -17.5% at 24 weeks and -8.7% to -24.2% at 48 weeks, compared to -1.6% in the placebo group